Global In-Situ Hybridization Market Research Report 2023

Report ID: 1898435 | Published Date: Jan 2025 | No. of Page: 90 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global In-Situ Hybridization Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Radioactive isotopes
        1.2.3 Non-radioactive labels
    1.3 Market by Application
        1.3.1 Global In-Situ Hybridization Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Cancer Diagnosis
        1.3.3 Immunology
        1.3.4 Neuroscience
        1.3.5 Cytology
        1.3.6 Infectious Diseases
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global In-Situ Hybridization Market Perspective (2017-2028)
    2.2 In-Situ Hybridization Growth Trends by Region
        2.2.1 In-Situ Hybridization Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 In-Situ Hybridization Historic Market Size by Region (2017-2022)
        2.2.3 In-Situ Hybridization Forecasted Market Size by Region (2023-2028)
    2.3 In-Situ Hybridization Market Dynamics
        2.3.1 In-Situ Hybridization Industry Trends
        2.3.2 In-Situ Hybridization Market Drivers
        2.3.3 In-Situ Hybridization Market Challenges
        2.3.4 In-Situ Hybridization Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top In-Situ Hybridization Players by Revenue
        3.1.1 Global Top In-Situ Hybridization Players by Revenue (2017-2022)
        3.1.2 Global In-Situ Hybridization Revenue Market Share by Players (2017-2022)
    3.2 Global In-Situ Hybridization Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by In-Situ Hybridization Revenue
    3.4 Global In-Situ Hybridization Market Concentration Ratio
        3.4.1 Global In-Situ Hybridization Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by In-Situ Hybridization Revenue in 2021
    3.5 In-Situ Hybridization Key Players Head office and Area Served
    3.6 Key Players In-Situ Hybridization Product Solution and Service
    3.7 Date of Enter into In-Situ Hybridization Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 In-Situ Hybridization Breakdown Data by Type
    4.1 Global In-Situ Hybridization Historic Market Size by Type (2017-2022)
    4.2 Global In-Situ Hybridization Forecasted Market Size by Type (2023-2028)
5 In-Situ Hybridization Breakdown Data by Application
    5.1 Global In-Situ Hybridization Historic Market Size by Application (2017-2022)
    5.2 Global In-Situ Hybridization Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America In-Situ Hybridization Market Size (2017-2028)
    6.2 North America In-Situ Hybridization Market Size by Country (2017-2022)
    6.3 North America In-Situ Hybridization Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe In-Situ Hybridization Market Size (2017-2028)
    7.2 Europe In-Situ Hybridization Market Size by Country (2017-2022)
    7.3 Europe In-Situ Hybridization Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific In-Situ Hybridization Market Size (2017-2028)
    8.2 Asia-Pacific In-Situ Hybridization Market Size by Country (2017-2022)
    8.3 Asia-Pacific In-Situ Hybridization Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America In-Situ Hybridization Market Size (2017-2028)
    9.2 Latin America In-Situ Hybridization Market Size by Country (2017-2022)
    9.3 Latin America In-Situ Hybridization Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa In-Situ Hybridization Market Size (2017-2028)
    10.2 Middle East & Africa In-Situ Hybridization Market Size by Country (2017-2022)
    10.3 Middle East & Africa In-Situ Hybridization Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Detail
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories In-Situ Hybridization Introduction
        11.1.4 Abbott Laboratories Revenue in In-Situ Hybridization Business (2017-2022)
        11.1.5 Abbott Laboratories Recent Development
    11.2 F. Hoffmann-La Roche
        11.2.1 F. Hoffmann-La Roche Company Detail
        11.2.2 F. Hoffmann-La Roche Business Overview
        11.2.3 F. Hoffmann-La Roche In-Situ Hybridization Introduction
        11.2.4 F. Hoffmann-La Roche Revenue in In-Situ Hybridization Business (2017-2022)
        11.2.5 F. Hoffmann-La Roche Recent Development
    11.3 Leica Biosystems Nussloch
        11.3.1 Leica Biosystems Nussloch Company Detail
        11.3.2 Leica Biosystems Nussloch Business Overview
        11.3.3 Leica Biosystems Nussloch In-Situ Hybridization Introduction
        11.3.4 Leica Biosystems Nussloch Revenue in In-Situ Hybridization Business (2017-2022)
        11.3.5 Leica Biosystems Nussloch Recent Development
    11.4 Agilent Technologies
        11.4.1 Agilent Technologies Company Detail
        11.4.2 Agilent Technologies Business Overview
        11.4.3 Agilent Technologies In-Situ Hybridization Introduction
        11.4.4 Agilent Technologies Revenue in In-Situ Hybridization Business (2017-2022)
        11.4.5 Agilent Technologies Recent Development
    11.5 Thermo Fisher Scientific
        11.5.1 Thermo Fisher Scientific Company Detail
        11.5.2 Thermo Fisher Scientific Business Overview
        11.5.3 Thermo Fisher Scientific In-Situ Hybridization Introduction
        11.5.4 Thermo Fisher Scientific Revenue in In-Situ Hybridization Business (2017-2022)
        11.5.5 Thermo Fisher Scientific Recent Development
    11.6 Merck
        11.6.1 Merck Company Detail
        11.6.2 Merck Business Overview
        11.6.3 Merck In-Situ Hybridization Introduction
        11.6.4 Merck Revenue in In-Situ Hybridization Business (2017-2022)
        11.6.5 Merck Recent Development
    11.7 PerkinElmer
        11.7.1 PerkinElmer Company Detail
        11.7.2 PerkinElmer Business Overview
        11.7.3 PerkinElmer In-Situ Hybridization Introduction
        11.7.4 PerkinElmer Revenue in In-Situ Hybridization Business (2017-2022)
        11.7.5 PerkinElmer Recent Development
    11.8 Exiqon A/S
        11.8.1 Exiqon A/S Company Detail
        11.8.2 Exiqon A/S Business Overview
        11.8.3 Exiqon A/S In-Situ Hybridization Introduction
        11.8.4 Exiqon A/S Revenue in In-Situ Hybridization Business (2017-2022)
        11.8.5 Exiqon A/S Recent Development
    11.9 BioGenex Laboratories
        11.9.1 BioGenex Laboratories Company Detail
        11.9.2 BioGenex Laboratories Business Overview
        11.9.3 BioGenex Laboratories In-Situ Hybridization Introduction
        11.9.4 BioGenex Laboratories Revenue in In-Situ Hybridization Business (2017-2022)
        11.9.5 BioGenex Laboratories Recent Development
    11.10 Advanced Cell Diagnostics
        11.10.1 Advanced Cell Diagnostics Company Detail
        11.10.2 Advanced Cell Diagnostics Business Overview
        11.10.3 Advanced Cell Diagnostics In-Situ Hybridization Introduction
        11.10.4 Advanced Cell Diagnostics Revenue in In-Situ Hybridization Business (2017-2022)
        11.10.5 Advanced Cell Diagnostics Recent Development
    11.11 Bio SB
        11.11.1 Bio SB Company Detail
        11.11.2 Bio SB Business Overview
        11.11.3 Bio SB In-Situ Hybridization Introduction
        11.11.4 Bio SB Revenue in In-Situ Hybridization Business (2017-2022)
        11.11.5 Bio SB Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global In-Situ Hybridization Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Radioactive isotopes
    Table 3. Key Players of Non-radioactive labels
    Table 4. Global In-Situ Hybridization Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global In-Situ Hybridization Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global In-Situ Hybridization Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global In-Situ Hybridization Market Share by Region (2017-2022)
    Table 8. Global In-Situ Hybridization Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global In-Situ Hybridization Market Share by Region (2023-2028)
    Table 10. In-Situ Hybridization Market Trends
    Table 11. In-Situ Hybridization Market Drivers
    Table 12. In-Situ Hybridization Market Challenges
    Table 13. In-Situ Hybridization Market Restraints
    Table 14. Global In-Situ Hybridization Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global In-Situ Hybridization Market Share by Players (2017-2022)
    Table 16. Global Top In-Situ Hybridization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Situ Hybridization as of 2021)
    Table 17. Ranking of Global Top In-Situ Hybridization Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by In-Situ Hybridization Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players In-Situ Hybridization Product Solution and Service
    Table 21. Date of Enter into In-Situ Hybridization Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global In-Situ Hybridization Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global In-Situ Hybridization Revenue Market Share by Type (2017-2022)
    Table 25. Global In-Situ Hybridization Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global In-Situ Hybridization Revenue Market Share by Type (2023-2028)
    Table 27. Global In-Situ Hybridization Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global In-Situ Hybridization Revenue Market Share by Application (2017-2022)
    Table 29. Global In-Situ Hybridization Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global In-Situ Hybridization Revenue Market Share by Application (2023-2028)
    Table 31. North America In-Situ Hybridization Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America In-Situ Hybridization Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe In-Situ Hybridization Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe In-Situ Hybridization Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific In-Situ Hybridization Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific In-Situ Hybridization Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America In-Situ Hybridization Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America In-Situ Hybridization Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa In-Situ Hybridization Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa In-Situ Hybridization Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Abbott Laboratories Company Detail
    Table 42. Abbott Laboratories Business Overview
    Table 43. Abbott Laboratories In-Situ Hybridization Product
    Table 44. Abbott Laboratories Revenue in In-Situ Hybridization Business (2017-2022) & (US$ Million)
    Table 45. Abbott Laboratories Recent Development
    Table 46. F. Hoffmann-La Roche Company Detail
    Table 47. F. Hoffmann-La Roche Business Overview
    Table 48. F. Hoffmann-La Roche In-Situ Hybridization Product
    Table 49. F. Hoffmann-La Roche Revenue in In-Situ Hybridization Business (2017-2022) & (US$ Million)
    Table 50. F. Hoffmann-La Roche Recent Development
    Table 51. Leica Biosystems Nussloch Company Detail
    Table 52. Leica Biosystems Nussloch Business Overview
    Table 53. Leica Biosystems Nussloch In-Situ Hybridization Product
    Table 54. Leica Biosystems Nussloch Revenue in In-Situ Hybridization Business (2017-2022) & (US$ Million)
    Table 55. Leica Biosystems Nussloch Recent Development
    Table 56. Agilent Technologies Company Detail
    Table 57. Agilent Technologies Business Overview
    Table 58. Agilent Technologies In-Situ Hybridization Product
    Table 59. Agilent Technologies Revenue in In-Situ Hybridization Business (2017-2022) & (US$ Million)
    Table 60. Agilent Technologies Recent Development
    Table 61. Thermo Fisher Scientific Company Detail
    Table 62. Thermo Fisher Scientific Business Overview
    Table 63. Thermo Fisher Scientific In-Situ Hybridization Product
    Table 64. Thermo Fisher Scientific Revenue in In-Situ Hybridization Business (2017-2022) & (US$ Million)
    Table 65. Thermo Fisher Scientific Recent Development
    Table 66. Merck Company Detail
    Table 67. Merck Business Overview
    Table 68. Merck In-Situ Hybridization Product
    Table 69. Merck Revenue in In-Situ Hybridization Business (2017-2022) & (US$ Million)
    Table 70. Merck Recent Development
    Table 71. PerkinElmer Company Detail
    Table 72. PerkinElmer Business Overview
    Table 73. PerkinElmer In-Situ Hybridization Product
    Table 74. PerkinElmer Revenue in In-Situ Hybridization Business (2017-2022) & (US$ Million)
    Table 75. PerkinElmer Recent Development
    Table 76. Exiqon A/S Company Detail
    Table 77. Exiqon A/S Business Overview
    Table 78. Exiqon A/S In-Situ Hybridization Product
    Table 79. Exiqon A/S Revenue in In-Situ Hybridization Business (2017-2022) & (US$ Million)
    Table 80. Exiqon A/S Recent Development
    Table 81. BioGenex Laboratories Company Detail
    Table 82. BioGenex Laboratories Business Overview
    Table 83. BioGenex Laboratories In-Situ Hybridization Product
    Table 84. BioGenex Laboratories Revenue in In-Situ Hybridization Business (2017-2022) & (US$ Million)
    Table 85. BioGenex Laboratories Recent Development
    Table 86. Advanced Cell Diagnostics Company Detail
    Table 87. Advanced Cell Diagnostics Business Overview
    Table 88. Advanced Cell Diagnostics In-Situ Hybridization Product
    Table 89. Advanced Cell Diagnostics Revenue in In-Situ Hybridization Business (2017-2022) & (US$ Million)
    Table 90. Advanced Cell Diagnostics Recent Development
    Table 91. Bio SB Company Detail
    Table 92. Bio SB Business Overview
    Table 93. Bio SB In-Situ HybridizationProduct
    Table 94. Bio SB Revenue in In-Situ Hybridization Business (2017-2022) & (US$ Million)
    Table 95. Bio SB Recent Development
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global In-Situ Hybridization Market Share by Type: 2021 VS 2028
    Figure 2. Radioactive isotopes Features
    Figure 3. Non-radioactive labels Features
    Figure 4. Global In-Situ Hybridization Market Share by Application in 2021 & 2028
    Figure 5. Cancer Diagnosis Case Studies
    Figure 6. Immunology Case Studies
    Figure 7. Neuroscience Case Studies
    Figure 8. Cytology Case Studies
    Figure 9. Infectious Diseases Case Studies
    Figure 10. In-Situ Hybridization Report Years Considered
    Figure 11. Global In-Situ Hybridization Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global In-Situ Hybridization Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global In-Situ Hybridization Market Share by Region: 2021 VS 2028
    Figure 14. Global In-Situ Hybridization Market Share by Players in 2021
    Figure 15. Global Top In-Situ Hybridization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Situ Hybridization as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by In-Situ Hybridization Revenue in 2021
    Figure 17. North America In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America In-Situ Hybridization Market Share by Country (2017-2028)
    Figure 19. United States In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe In-Situ Hybridization Market Share by Country (2017-2028)
    Figure 23. Germany In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific In-Situ Hybridization Market Share by Region (2017-2028)
    Figure 31. China In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America In-Situ Hybridization Market Share by Country (2017-2028)
    Figure 39. Mexico In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa In-Situ Hybridization Market Share by Country (2017-2028)
    Figure 43. Turkey In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia In-Situ Hybridization Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Abbott Laboratories Revenue Growth Rate in In-Situ Hybridization Business (2017-2022)
    Figure 46. F. Hoffmann-La Roche Revenue Growth Rate in In-Situ Hybridization Business (2017-2022)
    Figure 47. Leica Biosystems Nussloch Revenue Growth Rate in In-Situ Hybridization Business (2017-2022)
    Figure 48. Agilent Technologies Revenue Growth Rate in In-Situ Hybridization Business (2017-2022)
    Figure 49. Thermo Fisher Scientific Revenue Growth Rate in In-Situ Hybridization Business (2017-2022)
    Figure 50. Merck Revenue Growth Rate in In-Situ Hybridization Business (2017-2022)
    Figure 51. PerkinElmer Revenue Growth Rate in In-Situ Hybridization Business (2017-2022)
    Figure 52. Exiqon A/S Revenue Growth Rate in In-Situ Hybridization Business (2017-2022)
    Figure 53. BioGenex Laboratories Revenue Growth Rate in In-Situ Hybridization Business (2017-2022)
    Figure 54. Advanced Cell Diagnostics Revenue Growth Rate in In-Situ Hybridization Business (2017-2022)
    Figure 55. Bio SB Revenue Growth Rate in In-Situ Hybridization Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
F. Hoffmann-La Roche
Leica Biosystems Nussloch
Agilent Technologies
Thermo Fisher Scientific
Merck
PerkinElmer
Exiqon A/S
BioGenex Laboratories
Advanced Cell Diagnostics
Bio SB
Frequently Asked Questions
In-Situ Hybridization report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
In-Situ Hybridization report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
In-Situ Hybridization report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Instant Tea Premix

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More